These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2155684)

  • 41. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1985 May; 233(2):473-9. PubMed ID: 2987487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
    Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
    Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin depletion by 5,7-dihydroxytryptamine does not affect G protein subunit levels in rat cortex.
    Li PP; Law G; Green M; Chambers JW; Coscina DV; Warsh JJ
    Neurosci Lett; 1995 Jul; 194(3):153-6. PubMed ID: 7478226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo regulation of the serotonin-2 receptor in rat brain.
    Stockmeier CA; Kellar KJ
    Life Sci; 1986 Jan; 38(2):117-27. PubMed ID: 2935693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
    Alonso R; Soubrie P
    Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine.
    Sharma A; Punhani T; Fone KC
    Synapse; 1997 Sep; 27(1):45-56. PubMed ID: 9268064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
    Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
    Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of electroconvulsive shock on 5-HT2 and alpha 1-adrenoceptors and phosphoinositide signalling system in rat brain.
    Pandey GN; Pandey SC; Isaac L; Davis JM
    Eur J Pharmacol; 1992 Aug; 226(4):303-10. PubMed ID: 1327845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine.
    Sijbesma H; Schipper J; de Kloet ER; Mos J; van Aken H; Olivier B
    Pharmacol Biochem Behav; 1991 Feb; 38(2):447-58. PubMed ID: 1829232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 52. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
    Frankfurt M; Allen DL; Luine VN; Beaudet A
    Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin receptor activation of phosphoinositide turnover in uterine, fundal, vascular, and tracheal smooth muscle.
    Cohen ML; Wittenauer LA
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):176-81. PubMed ID: 2441168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat.
    Claustre Y; Rouquier L; Scatton B
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1051-6. PubMed ID: 2855237
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensitivity of spinal reflexes to TRH and 5-HT in 5,6-dihydroxytryptamine-treated rats.
    Nagano N; Ono H; Ozawa M; Fukuda H
    Eur J Pharmacol; 1987 Jul; 139(3):315-21. PubMed ID: 3117574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis.
    Wolf WA; Schutz LJ
    J Neurochem; 1997 Oct; 69(4):1449-58. PubMed ID: 9326273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.
    Quattrone A; Schettini G; Annunziato L; Di Renzo G
    Eur J Pharmacol; 1981 Nov; 76(1):9-13. PubMed ID: 7318925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine.
    Göthert M; Schlicker E
    Life Sci; 1983 Mar; 32(11):1183-91. PubMed ID: 6572776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
    Claustre Y; Eudeline B; Benavides J; Scatton B
    Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.